Related references
Note: Only part of the references are listed.Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Haythum O. Tayeb et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
J. Li et al.
NEUROLOGY (2011)
The future of Alzheimer's disease: The next 10 years
Harald Hampel et al.
PROGRESS IN NEUROBIOLOGY (2011)
Prevention in Psychiatry: Effects of Healthy Lifestyle on Cognition
David A. Merrill et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2011)
Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
Murat Emre et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Predictors of adherence among Alzheimer's disease patients receiving oral therapy
Bijan Borah et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors
Massimo Musicco et al.
JOURNAL OF NEUROLOGY (2009)
Cardiovascular risk factors and dementia
Howard Fillit et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch
Gary Small et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Is cholesterol a culprit in Alzheimer's disease?
DL Sparks et al.
INTERNATIONAL PSYCHOGERIATRICS (2003)
Share Paper
